Phone:1-206-878-3900, Fax:1-888-878-1118 customerservice@keycompounding.com
Congress Acts to Preserve Patient Access to Compounded Medications

Congress Acts to Preserve Patient Access to Compounded Medications

In a considerable win for patients who need compounded medications, the International Academy of Compounding Pharmacists (IACP), working with the DQSA Coalition, is very pleased to announce that the President has signed the Congressional Omnibus bill into law, H.R. 244, which provides funding through September 30, 2017, and includes language that addresses the Memorandum of Understanding, office-use, and pharmacy inspections.

Low Dose Naltrexone

Low Dose Naltrexone

Marie Antoinette’s quote is a great reminder that at times, new uses can be found with old things, such is the case with the drug Naltrexone. First synthesized as a competitive opioid antagonist in 1963, for many years research on Naltrexone remained dormant until

^